Tiziana Life Sciences PLC
ANTI-CD3 ANTIBODY FORMULATIONS
Last updated:
Abstract:
This invention relates to therapeutic, diagnostic and/or prophylactic formulations and dosages and dosing regimens of anti-CD3 antibodies, as well as to methods for using such formulations and dosages and dosing regimens.
Status:
Application
Type:
Utility
Filling date:
18 May 2020
Issue date:
7 Jan 2021